首页> 外文期刊>Molecules >Erubescensoic Acid, a New Polyketide and a Xanthonopyrone SPF-3059-26 from the Culture of the Marine Sponge-Associated Fungus Penicillium erubescens KUFA 0220 and Antibacterial Activity Evaluation of Some of Its Constituents
【24h】

Erubescensoic Acid, a New Polyketide and a Xanthonopyrone SPF-3059-26 from the Culture of the Marine Sponge-Associated Fungus Penicillium erubescens KUFA 0220 and Antibacterial Activity Evaluation of Some of Its Constituents

机译:海洋海绵相关真菌青霉KUFA 0220培养物中的芥兰酸,新的聚酮化合物和黄嘌呤酮SPF-3059-26及其某些成分的抗菌活性评估

获取原文
           

摘要

A new polyketide erubescensoic acid (1), and the previously reported xanthonopyrone, SPF-3059-26 (2), were isolated from the uninvestigated fractions of the ethyl acetate crude extract of the marine sponge-associated fungus Penicillium erubescens KUFA0220. The structures of the new compound, erubescensoic acid (1), and the previously reported SPF-3059-26 (2), were elucidated by extensive analysis of 1D and 2D-NMR spectra as well as HRMS. The absolute configuration of the stereogenic carbon of erubescensoic acid (1) was determined by X-ray analysis. Erubescensoic acid (1) and SPF-3059-26 (2), together with erubescenschromone B (3), penialidin D (4), and 7-hydroxy-6-methoxy-4-oxo-3-[(1E)-3-oxobut-1-en-1-yl]-4H-chromen-5-carboxylic acid (5), recently isolated from this fungus, were assayed for their antibacterial activity against gram-positive and gram-negative reference strains and the multidrug-resistant (MDR) strains from the environment. The capacity of these compounds to interfere with the bacterial biofilm formation and their potential synergism with clinically relevant antibiotics for the MDR strains were also investigated.
机译:从海洋海绵相关真菌铜青霉KUFA0220的乙酸乙酯未提取物的未经研究的级分中分离出一种新的聚酮化合物芥蓝酸(1)和先前报道的黄嘌呤酮SPF-3059-26(2)。通过对1D和2D-NMR谱图以及HRMS进行广泛分析,阐明了新化合物芥兰酸(1)和先前报道的SPF-3059-26(2)的结构。通过X射线分析确定了芥蓝酸(1)的立体碳的绝对构型。芥兰酸(1)和SPF-3059-26(2)以及芥兰色酮B(3),Penialidin D(4)和7-羟基-6-甲氧基-4-氧代-3-[(1E)-3最近从该真菌中分离出的-oxobut-1-en-1-yl] -4H-chromen-5-羧酸(5)对革兰氏阳性和革兰氏阴性参考菌株以及多种药物-抗性(MDR)菌株来自环境。还研究了这些化合物干扰细菌生物膜形成的能力及其与MDR菌株临床相关抗生素的潜在协同作用。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号